These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 20542439)
1. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. Vangveravong S; Taylor M; Xu J; Cui J; Calvin W; Babic S; Luedtke RR; Mach RH Bioorg Med Chem; 2010 Jul; 18(14):5291-300. PubMed ID: 20542439 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of selective dopamine D2 receptor antagonists. Vangveravong S; McElveen E; Taylor M; Xu J; Tu Z; Luedtke RR; Mach RH Bioorg Med Chem; 2006 Feb; 14(3):815-25. PubMed ID: 16288878 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound. Vangveravong S; Zhang Z; Taylor M; Bearden M; Xu J; Cui J; Wang W; Luedtke RR; Mach RH Bioorg Med Chem; 2011 Jun; 19(11):3502-11. PubMed ID: 21536445 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds. Luedtke RR; Mishra Y; Wang Q; Griffin SA; Bell-Horner C; Taylor M; Vangveravong S; Dillon GH; Huang RQ; Reichert DE; Mach RH ACS Chem Neurosci; 2012 Dec; 3(12):1050-62. PubMed ID: 23259040 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands. Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH J Med Chem; 2001 May; 44(11):1815-26. PubMed ID: 11356115 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor. Austin NE; Avenell KY; Boyfield I; Branch CL; Hadley MS; Jeffrey P; Johnson CN; Macdonald GJ; Nash DJ; Riley GJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Wood MD Bioorg Med Chem Lett; 2001 Mar; 11(5):685-8. PubMed ID: 11266169 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands. Li A; Mishra Y; Malik M; Wang Q; Li S; Taylor M; Reichert DE; Luedtke RR; Mach RH Bioorg Med Chem; 2013 Jun; 21(11):2988-98. PubMed ID: 23618707 [TBL] [Abstract][Full Text] [Related]
8. The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition. Huang R; Griffin SA; Taylor M; Vangveravong S; Mach RH; Dillon GH; Luedtke RR Pharmacology; 2013; 92(1-2):84-9. PubMed ID: 23942137 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and D2-like binding affinity of 4,5-dihydro-1H-benzo[g]indole-3-carboxamide derivatives as conformationally restricted 5-phenyl-pyrrole-3-carboxamide analogs. Pinna GA; Curzu MM; Sechi M; Chelucci G; Vianello P; Maciocco E Farmaco; 1998; 53(10-11):684-9. PubMed ID: 10205854 [TBL] [Abstract][Full Text] [Related]
10. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists. Pugsley TA; Shih YH; Whetzel SZ; Zoski K; Van Leeuwen D; Akunne H; Mackenzie R; Heffner TG; Wustrow D; Wise LD Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):219-26. PubMed ID: 11817497 [TBL] [Abstract][Full Text] [Related]
11. Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps. Löber S; Hübner H; Gmeiner P Bioorg Med Chem Lett; 1999 Jan; 9(1):97-102. PubMed ID: 9990464 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands. Huang Y; Kegeles LS; Bae S; Hwang D; Roth BL; Savage JE; Laruelle M Bioorg Med Chem Lett; 2001 Jun; 11(11):1375-7. PubMed ID: 11378358 [TBL] [Abstract][Full Text] [Related]
13. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity. Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566 [TBL] [Abstract][Full Text] [Related]
14. Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR. Grundt P; Husband SL; Luedtke RR; Taylor M; Newman AH Bioorg Med Chem Lett; 2007 Feb; 17(3):745-9. PubMed ID: 17095222 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, in silico, and in vitro studies of novel dopamine D Elek M; Djokovic N; Frank A; Oljacic S; Zivkovic A; Nikolic K; Stark H Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000486. PubMed ID: 33615541 [TBL] [Abstract][Full Text] [Related]
16. Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists. Bettinetti L; Schlotter K; Hübner H; Gmeiner P J Med Chem; 2002 Oct; 45(21):4594-7. PubMed ID: 12361386 [TBL] [Abstract][Full Text] [Related]
17. 1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligands. Thurkauf A; Chen X; Zhang S; Gao Y; Kieltyka A; Wasley JW; Brodbeck R; Greenlee W; Ganguly A; Zhao H Bioorg Med Chem Lett; 2003 Sep; 13(17):2921-4. PubMed ID: 14611858 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626. Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560 [TBL] [Abstract][Full Text] [Related]